.png)
The Molecular Induced Stem Cell Processing Platform is a groundbreaking biotechnology developed by the Taiwan Pharmaceutical Technology Center and marketed globally by ACE Biolabs. It has become a unique, leading technology in the international market. This platform is specifically designed for researchers and biotechnology companies looking to enhance the efficacy of mesenchymal stem cells (MSCs).
Our Molecular Induced Stem Cell Processing Platform , with its exclusive patented technology and advanced molecular induction processes, provides unprecedented enhancement options for MSCs. Through these cutting-edge technologies, MSCs demonstrate significantly stronger effects in immune modulation, anti-aging, hair regeneration, and promoting mitochondrial health, greatly enhancing their potential in various regenerative medicine and biotechnology applications.
Our Advantages：
.jpg)
Currently, the use of molecular induction (priming) technology to enhance the
multiple functions of mesenchymal stem cells (MSCs) has been clearly identified in research.
These functions primarily include:
(2).png)
.png)